Chronic liver injury related to use of bentazepam: an unusual instance of benzodiazepine hepatotoxicity.

Abstract

Liver injury induced by benzodiazepines is rare and is classified as an unpredictable or idiosyncratic hepatotoxic reaction. Early reports indicated that in most cases the pattern of liver injury was cholestatic. We describe three patients with persistent increases in liver transaminase levels after several weeks of treatment with bentazepam, a benzodiazepine marketed in Spain for anxiety disorders. In all cases withdrawal of the drug was followed by resolution of transaminase level abnormalities. A liver biopsy (done in one patient only) showed histological evidence of severe chronic active hepatitis. In conclusion, these findings, together with two previously published case reports, suggest that a benzodiazepine can cause chronic hepatitis and argue in favor of using liver function tests to monitor all patients taking bentazepam.

• Authors: R J Andrade, M I Lucena, J Aguilar, M D Lazo, R Camargo, P Moreno, M D García-Escaño, A Marquez, R Alcántara, G Alcáin
• Journal: Digestive diseases and sciences (Dig Dis Sci) Vol. 45 Issue 7 Pg. 1400-4 (Jul 2000) ISSN: 0163-2116 [Print] United States
• PMID: 10961721 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Anti-Anxiety Agents
• Azepines
• Benzodiazepines
• bentazepam

Topics

• Administration, Oral
• Anti-Anxiety Agents (poisoning)
• Azepines (poisoning)
• Benzodiazepines (poisoning)
• Chemical and Drug Induced Liver Injury, Chronic (pathology)
• Female
• Humans
• Middle Aged